About
20.05EUR+0.39 +1.98%
Closed • Updated at 21:35 GMT+00:00Market Cap$411.61M
Volume19.0K
Beta1.64
RSI56.63
Gross Margin8.04%
Formycon Ag — investor relations, events, news, and company updates on 6ix.
Latest News
Dec 23 2025
Zydus Partners with Bioeq for U.S. Commercialisation rights for NUFYMCO®, an Interchangeable Biosimilar to Lucentis®
Dec 9 2025
Formycon and Zydus partner for exclusive licensing and supply agreement of FYB206, a biosimilar to Keytruda® (Pembrolizumab), in the U.S. and Canada
Dec 4 2025
Formycon and MS Pharma sign exclusive commercialization partnership for Keytruda® biosimilar candidate FYB206 for the MENA Region
Oct 21 2025
Polpharma Biologics announces commercial launch of Europe’s first Pre-filled Syringe presentation of a ranibizumab biosimilar
Jul 30 2025
Formycon Invites to Conference Call on 2025 Half-year Results and Announces Participation in International Investor Conferences in the 3rd Quarter of 2025
Community Chat
Ask AI
Try asking
